What is Cisen Pharmaceutical Co., Ltd.'s (603367.SS) StockRank?

MoatMap's StockRank for Cisen Pharmaceutical Co., Ltd. (603367.SS) is 81/100, with a Strong Buy signal. This is a composite score combining Quality (71), Value (69), and Momentum (29) factor ranks across MoatMap's 20,000+ stock universe.

Does Cisen Pharmaceutical Co., Ltd. have an economic moat?

Cisen Pharmaceutical Co., Ltd. (603367.SS) has a Quality factor score of 71/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Cisen Pharmaceutical Co., Ltd. a buy, hold, or sell?

MoatMap's current signal for Cisen Pharmaceutical Co., Ltd. (603367.SS) is Strong Buy, based on a StockRank of 81/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Cisen Pharmaceutical Co., Ltd. in?

Cisen Pharmaceutical Co., Ltd. (603367.SS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

603367.SS

STRONG BUYREMOVE

Cisen Pharmaceutical Co., Ltd. · Healthcare · China · $934M · Avg Vol: $10M/d

StockRank

P/E (TTM)

14.9x

ROE

6.6%

D/E

0.0x

Dividend %

2.6%

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Cisen Pharmaceutical is a generic drug manufacturer with thin margins and high exposure to rising active pharmaceutical ingredient (API) input costs. It lacks the proprietary platform or CDMO pricing power required to benefit from the biotech innovation cycle.

COMPANY DESCRIPTION

Cisen Pharmaceutical specializes in the R&D, manufacturing, and sales of chemical generic drugs, focusing on large-volume parenterals (infusions), specialty injections, and solid oral dosages. The company's competitive moat is sustained by its massive, cost-efficient manufacturing capacity, extensive hospital sales network, and successful participation in China's National Volume-Based Procurement (VBP) program. It operates as a leading domestic pharmaceutical manufacturer, transitioning toward innovative small-molecule and biopharmaceutical drug development.

FINANCIAL SUMMARY (USD)

Year	2022	2023	2024	2025	CAGR
Revenue	601M	660M	588M	509M	-5.4%
EPS	0.11	0.17	0.17	0.14	6.5%
Shares	453M	453M	453M	453M	-0.1%
Debt	23M	25M	17M	6M	-35.0%
Equity	788M	846M	879M	915M	5.1%
Op CF	38M	67M	84M	69M	21.8%
Inv CF	-40M	-56M	-3M	-26M	—
Fin CF	16M	-20M	-54M	-34M	—

PRICE (1M)-16.0%

SMA 50SMA 200

$1.95

RSI (14)

39.4

52W High

$5.09

From 52W High

0.4%

SCORE BREAKDOWN

Quality

ROIC

7.8%66.5

ROE

6.6%61.3

GP/Assets

21.9%50.1

Op. Margin

17.7%79.1

FCF/Assets

6.0%74.7

Piotroski

—83.4

Int. Cover

50.0x91.4

D/E Ratio

0.01x91.1

Current Ratio

4.65x68.4

Value

P/E (TTM)

14.9x73.3

EV/EBITDA

5.4x56.2

P/FCF

94.6x74.2

P/B

1.0x80.0

P/S

1.8x70.6

Div Yield

2.6%61.5

Momentum

52W High %

38%11.1

RS 6M

-34%35.6

SMA 50/200

0.80x13.2

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

+59%58.3

Q Growth

-9%33.4

FUNDAMENTALS

Market Cap

$934M

P/E (Forward)

9.4x

Gross Margin

49.0%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 603367.SS are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
603367.SS	Cisen Pharmaceutical Co., Ltd.(you)	$934M	81	STRONG BUY
002390.SZ	Guizhou Xinbang Pharmaceutical Co., Ltd.	$870M	81	STRONG BUY
002349.SZ	Jinghua Pharmaceutical Group Co., Ltd.	$866M	85	STRONG BUY
600664.SS	Harbin Pharmaceutical Group Co., Ltd.	$1.3B	81	STRONG BUY
002437.SZ	HARBIN GLORIA PHARMACEUTICALS Co., LTD	$975M	73	BUY
603676.SS	Tibet Weixinkang Medicine Co., Ltd.	$594M	83	STRONG BUY
002737.SZ	Sunflower Pharmaceutical Group Co.,Ltd	$1.1B	88	STRONG BUY
002332.SZ	Zhejiang Xianju Pharmaceutical Co.,Ltd.	$1.2B	87	STRONG BUY
000989.SZ	Jiuzhitang Co., Ltd.	$1.0B	91	STRONG BUY
603439.SS	Guizhou Sanli Pharmaceutical Co.,Ltd	$984M	70	BUY

Peer medians: ROE 4.7% · P/E 27.9x · Gross margin 53.1%

Cisen Pharmaceutical Co., Ltd. (603367.SS) — Stock Score Summary

Cisen Pharmaceutical Co., Ltd. (603367.SS) has a MoatMap StockRank of 81/100 based on Quality (71/100), Value (69/100), and Momentum (29/100) factor scores. The current signal is STRONG BUY. Cisen Pharmaceutical is a generic drug manufacturer with thin margins and high exposure to rising active pharmaceutical ingredient (API) input costs. It lacks the proprietary platform or CDMO pricing power required to benefit from the biotech innovation cycle.

Key Financial Metrics

Price	$1.95
Market Cap	$934M
P/E (TTM)	14.87
P/E (Forward)	9.36
Price/Book	0.96
Return on Equity	6.6%
Return on Invested Capital	7.8%
Debt/Equity	0.66
Gross Margin	49.0%
Operating Margin	17.7%
Revenue Growth	-7.6%
Dividend Yield	2.6%
Free Cash Flow	$10M

Cisen Pharmaceutical Co., Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Cisen Pharmaceutical Co., Ltd.’s (603367.SS) StockRank?: MoatMap’s StockRank for Cisen Pharmaceutical Co., Ltd. (603367.SS) is 81/100, with a Strong Buy signal. It is a composite of Quality (71), Value (69), and Momentum (29) factor ranks across MoatMap’s 20,000+ stock universe.
Does Cisen Pharmaceutical Co., Ltd. have an economic moat?: Cisen Pharmaceutical Co., Ltd. (603367.SS) has a Quality factor score of 71/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Cisen Pharmaceutical Co., Ltd. a buy, hold, or sell?: MoatMap’s current signal for Cisen Pharmaceutical Co., Ltd. (603367.SS) is Strong Buy, based on a StockRank of 81/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Cisen Pharmaceutical Co., Ltd. in?: Cisen Pharmaceutical Co., Ltd. (603367.SS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).